Prime Medicine, Inc. (NYSE:PRME) Given Consensus Rating of “Moderate Buy” by Analysts
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month […]
More Stories
CIBC Private Wealth Group LLC Has $33,000 Stock Position in Fox Co. (NASDAQ:FOXA)
CIBC Private Wealth Group LLC increased its holdings in shares of Fox Co. (NASDAQ:FOXA – Free Report) by 122.3% during...
O Shaughnessy Asset Management LLC Sells 1,036 Shares of Qualys, Inc. (NASDAQ:QLYS)
O Shaughnessy Asset Management LLC reduced its stake in Qualys, Inc. (NASDAQ:QLYS – Free Report) by 21.2% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...